Clinical Trials Logo

Clinical Trial Summary

Spondyloarthrosis is a degenerative disease involving the intervertebral disc, vertebral bodies, and adjacent soft tissues. Treatment aims to slow disease progression and manage symptoms through an interdisciplinary approach.It can be conservative, pharmacological and interventional, rarely chirurgic. This study aimed to evaluate the effectiveness of a rehabilitation program combined with Pridinol Mesylate in the treatment of Spondyloarthrosis in elderly patients in terms of pain resolution, improving disability, and quality of life versus single treatment. A randomized controlled trial was conducted in patients with spondyloarthritis. The patients recruited were divided into three groups: the Combined Group (CG), who received a rehabilitation program combined with Pridinol Mesylate; the Rehabilitation Group (RG), who received only the same rehabilitation program; and the Drug Group (DG), who received only the administration of the drug.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06252064
Study type Interventional
Source University of Palermo
Contact
Status Completed
Phase N/A
Start date March 1, 2022
Completion date January 15, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03459274 - Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
Active, not recruiting NCT02948608 - Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis
Completed NCT03064815 - The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies N/A
Completed NCT00383617 - Referral Recommendations for Axial Spondyloarthritis N/A
Completed NCT04673825 - Monitoring Spondyloarthritis With SpA-Net N/A
Completed NCT01718951 - Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial Phase 4
Completed NCT03287596 - Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI N/A
Recruiting NCT05431283 - Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy
Completed NCT02960035 - A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis Phase 4